Do the Five Combinations of Suicidal Ideation in the FDA 2012 Draft Guidance Document and the C–SSRS Adequately Cover All Suicidal Ideation Combinations in Practice? A Case Study.
Objective: The United States Food and Drug Administration’s newest classification system for suicidality assessment anchors suicidal ideation to various combinations of passive suicidal ideation, active suicidal ideation, method, intent, and plan. This is based upon the suicidal ideation categories...
| Publicado en: | Innovations in Clinical Neuroscience Vol. 11; no. 9/10; pp. 172 - 179 |
|---|---|
| Autores principales: | , |
| Formato: | case study pictorial research Journal Article |
| Publicado: |
Matrix Medical Communications, LLC
Sep/Oct2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=100084987&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 100084987 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 21588333 DAD5 jtl: Innovations in Clinical Neuroscience issn: 21588333 maglogo: N pubinfo: dt: Sep/Oct2014 vid: 11 iid: 9/10 pid: 33670 pub: Matrix Medical Communications, LLC place: West Chester, Pennsylvania artinfo: ui: 100084987 100084987 103863081 100084987 ppf: 172 ppct: 7 formats: fmt: @attributes: type: P tig: atl: Do the Five Combinations of Suicidal Ideation in the FDA 2012 Draft Guidance Document and the C–SSRS Adequately Cover All Suicidal Ideation Combinations in Practice? A Case Study. aug: au: GIDDENS, JENNIFER M. SHEEHAN, DAVID V. affil: Co-founder, Tampa Center for Research on Suicidality, Tampa, Florida. sug: subj: Suicidal Ideation Classification United States Food and Drug Administration Female Type II Error Scales Diaries Adult Depression Complications Pervasive Developmental Disorder-Not Otherwise Specified Diagnosis Asperger Syndrome Diagnosis Algorithms Human Adult: 19-44 years Female ab: Objective: The United States Food and Drug Administration’s newest classification system for suicidality assessment anchors suicidal ideation to various combinations of passive suicidal ideation, active suicidal ideation, method, intent, and plan. This is based upon the suicidal ideation categories in the Columbia–Suicide Severity Rating Scale. Although there are 32 possible combinations of these suicidal ideation phenomena, the Food and Drug Administration’s 2012 system and the Columbia–Suicide Severity Rating Scale accommodate six combinations. We use a case study to explore the impact of possible type II errors on suicidality classification posed by not including remaining 26 possible categories. Methods: A suicidal subject kept detailed daily records of her experience of suicidality over two separate intervals of eight-months’ and nine-months’ duration. These records permitted classification of individual events into each of the possible 32 suicidal ideation combinations. Results: Although only a small percentage of all events of suicidality from either collection period fell outside of the Food and Drug Administration’s classification system and the Columbia –Suicide Severity Rating Scale categories, those that were not so categorized constituted a large percentage of the time this subject experienced suicidality. When these two timeframes were aggregated, more than half of the subject’s time spent experiencing suicidality fell into the suicidal ideation combinations not captured by the Food and Drug Administration’s classification system and the Columbia–Suicide Severity Rating Scale categories. Conclusion: This case study suggests that type II errors in the Food and Drug Administration’s classification system and in the Columbia–Suicide Severity Rating Scale categories for suicidal ideation may represent important omissions. pubtype: Academic Journal doctype: case study pictorial research Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|